SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-008177
Filing Date
2022-04-04
Accepted
2022-04-04 16:16:31
Documents
13
Period of Report
2022-04-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20220404_8k.htm   iXBRL 8-K 35812
  Complete submission text file 0001437749-22-008177.txt   172375

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arav-20220401.xsd EX-101.SCH 3600
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220401_def.xml EX-101.DEF 11918
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220401_lab.xml EX-101.LAB 15965
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220401_pre.xml EX-101.PRE 12129
7 EXTRACTED XBRL INSTANCE DOCUMENT arav20220404_8k_htm.xml XML 2655
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 22802418
SIC: 2834 Pharmaceutical Preparations